ZENROSIB
Live / Allowed — Notice of allowance issued (as of 23 Sept 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 27 Nov 2024 filing date already counts against anyone who files later.
Record
- Serial number
- 98876362
- Mark type
- Stylized text
- Filed
- 27 Nov 2024
- Published for opposition
- 29 Jul 2025
- Attorney of record
- Joshua S. Jarvis
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and pharmaceutical products for use in oncology diseases and disorders
Owner
- Nuvalent, Inc., Cambridge, MA, US
- Nuvalent, Inc., Cambridge, MA, US
Prosecution history
- 23 Sept 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 29 Jul 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 29 Jul 2025 — PUBLISHED FOR OPPOSITION
- 23 Jul 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Jun 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Jun 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 20 Jun 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 20 Jun 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 May 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 May 2025 — NON-FINAL ACTION E-MAILED
- 20 May 2025 — NON-FINAL ACTION WRITTEN
- 20 May 2025 — ASSIGNED TO EXAMINER
- 15 May 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 27 Nov 2024 — NEW APPLICATION ENTERED